Emerging Infectious Disease ISSN: 1080-6059

Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA

Scott K. Heysell

, Jane L. Moore, Suzanne J. Keller, and Eric R. Houpt

Author affiliations: Author affiliations: University of Virginia, Charlottesville, Virginia, USA (S.K. Heysell, E.R. Houpt); Virginia Department of Health, Richmond, Virginia, USA (J.L. Moore, S.J. Keller)

Main Article

Figure 1

Results of serum concentration 2 hours after medication administration levels (C2hr) of first-line antituberculosis medications among patients with a slow response to tuberculosis therapy. Frequencies are reported for low, within target, and high C2hr levels corresponding to levels below, within, or above the expected range for each medication.

Figure 1. Results of serum concentration 2 hours after medication administration levels (C_2hr) of first-line antituberculosis medications among patients with a slow response to tuberculosis therapy. Frequencies are reported for low, within target, and high C_2hr levels corresponding to levels below, within, or above the expected range for each medication.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.